New Ivermectin Study Finds “Significant Reduction” in COVID-19 Deaths


A prospective study focused on the role of ivermectin in the fight against SARS-CoV-2 published as examined by the companion American Journal of Therapeutics.

Consistent with the abstract of the study, Drs. Tess Lawrie (MBBCh, PhD), a medical evidence EXPERTS, and his team “Evaluated the efficacy of ivermectin treatment in reducing mortality, secondary outcome, and chemoprophylaxis, among individuals with, or at high risk of, COVID-19 infection.”

Ivermectin, an anti-parasitic drug with both antiviral and anti-inflammatory properties, is used by doctors around the world as both a treatment and a prophylactic for COVID-19, the disease caused by SARS-CoV -2.

While governments and public health officials have tried to find solutions to the disease to work with it, some doctors and scientists have gone to rely on, though also repeated, medications — a custom that is not uncommon when face a new or unexpected situation.

Despite the safety and available anecdotal evidence, critics of drug use are quick to point out the lack of studies reviewed by colleagues using ivermectin to treat viral infection and consequent disease.

In response to criticisms and consequent attacks on ivermectin use by Big Tech, Big Pharma, and public health organizations around the world, Drs. Lawrie and his team have bibliographic databases until April 25 this year. The authors “Filtered for studies, obtained data, and assessed the risk of bias” before conducting a meta-analysis that resulted in the inclusion of 24 randomized control trials involving 3,406 participants.

The study authors conclude that “Significant reduction in mortality with COVID-19 is possible with the use of ivermectin.” Safe and effective medicine “It’s likely to have a significant impact on SARS-CoV-2 pandemic around the world. ”

Dr. told. Lawrie TestSite:

We are happy to have a product of many months of hard work that has finally been published! And what a great team of writers – it is an honor to work with people with such high integrity, who maintain a spirit of hope and optimism despite all the difficulties we face. Thanks for not giving! Now the authorities have all the evidence they need to immediately approve ivermectin.. ”

A similar conclusion was also reached by several expert groups from UK, Italy, Spain, US, and a group from Japan led by Nobel Prize -winning discoverer of ivermectin, professor Satoshi Omura.

The study also reflects what has been observed in other studies “From Bangladesh and India to Peru and Argentina; from Israel and Nigeria to ICON studies in South Florida and public health initiatives using ivermectin from Mexico City to Uttar Pradesh, India,” reports TestSite News.

Although increased censorship with ivermectin across Big Tech social media platforms and search engines, the response to the social media study has been largely positive and continues to grow.

Awareness of the effectiveness of ivermectin and its adoption by physicians around the world to successfully treat COVID-19 continues to accelerate.

This article is free and open source. You have permission to publish it in a Creative Commons license with delivery of COVID19Up.org.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *